Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sanofi Ord Shs SNYNF

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood... see more

Recent & Breaking News (OTCPK:SNYNF)

Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes

GlobeNewswire June 14, 2014

CQDM and Sanofi Canada partner to accelerate drug discovery

Canada NewsWire June 12, 2014

Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR

PR Newswire June 12, 2014

Sanofi to Present New Clinical Data at American Diabetes Association 74th Scientific Sessions

PR Newswire June 10, 2014

RXi Pharma Advances sd-rxRNA Platform with Key Patent

Accesswire June 9, 2014

Global Pressure Mounts to Revoke Russia's Hosting of FIFA's 2018 World Cup

Business Wire June 5, 2014

Canadian Study Identifies New Approach To Improving Care For Millions of People Living with Type 2 Diabetes

Canada NewsWire June 4, 2014

Wellness Not the Focus of Health Benefit Plans

Canada NewsWire June 3, 2014

Québec to fund treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Canada NewsWire June 2, 2014

Genzyme's Lemtrada Resubmission Accepted for Review by FDA

Business Wire May 30, 2014

Genzyme Recognizes Sixth Annual World MS Day

Business Wire May 28, 2014

Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC

Canada NewsWire May 28, 2014

Genzyme's Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)

Business Wire May 27, 2014

Rolaids® "Eat Your Words" Spelling Bee Celebrates America's Favorite, Yet Heartburn-Inducing Foods

PR Newswire May 22, 2014

Sanofi Pasteur Announces Favorable Phase II Study Results for Investigational Clostridium difficile Vaccine at the American Society for Microbiology Meeting

Canada NewsWire May 19, 2014

Sanofi Canada Inspires Next Generation of Canadian Scientists at "Destination Innovation" Event

Canada NewsWire May 15, 2014

Jerome Bettis, Sanofi US and Allergy Foundation Launch Severe, Life-Threatening Allergies Quiz

PR Newswire May 13, 2014

Veterans Advancing ALS/MND Wins Sanofi US Innovation Challenge: Collaborate Innovate

PR Newswire May 12, 2014

National Survey Reveals Mothers Are Unaware of the CDC Recommendations for Prevention of Meningococcal Meningitis, a Disease That Can Potentially Kill in 24 Hours

PR Newswire May 12, 2014

North American Pharma-Biotech Sector to Wrap Up Construction on 116 Projects Worth $3.7 Billion in Second-Quarter 2014, an Industrial Info News Alert

Marketwired May 12, 2014